1.
A Dutch Administrative Database in Support of Economic Evaluations: A Feasibility Study
2.
3.
4.
Cost-Effectiveness Of Omalizumab In Chronic Spontaneous Urticaria In The Netherlands
Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012
Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis
Systematic review of available evidence on 11 high-priced inpatient orphan drugs
PMH9 THE SOCIO-ECONOMIC BURDEN OF BIPOLAR DISORDER IN THE NETHERLANDS